Pittsburg, PA

Tucker Arensberg, P.C.
Tucker Arensberg, P.C.
One PPG Place, Suite 1500
Pittsburgh, PA 15222
(412) 566-1212
(412) 594-5619
Directions to Pittsburgh

Harrisburg, PA

Tucker Arensberg, P.C.
Tucker Arensberg, P.C.
300 Corporate Center Drive, Suite 200
Camp Hill, PA 17011
(717) 234-4121
(717) 232-6802
Directions to Harrisburg

New York, NY

Tucker Arensberg, P.C.
Tucker Arensberg, P.C.
250 Park Avenue, Suite 1508, 7th Floor
New York, NY 10171
(212) 739-7910
(212) 739-9607
Directions to New York

Foster City, CA

Tucker Arensberg, P.C.
Tucker Arensberg, P.C.
1098 Foster City Boulevard, Suite 106 #700
Foster City, California 94404
(650)208-2701
Directions to Foster City

Widget Title

  • People
  • Practice Areas
  • News + Insights
    • News
    • Articles
    • Speaking
  • Office Locations
    • Pittsburgh
    • Harrisburg
    • New York
    • Foster City
  • About the Firm
    • Overview
    • Careers
    • Diversity
    • Women@Tucker
    • Affiliations
    • Pro Bono & Community

Title

  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Tucker Arensberg, P.C.Tucker Arensberg, P.C.

Attorneys in Pittsburgh, Harrisburg, New York City

  • People
  • Practice Areas
  • News + Insights
  • About Our Firm
  • COVID 19: Answers to Business Challenges
ShareBookmarkPDF

Bill Introduced in U.S. Senate by International Narcotics Control Caucus in Favor of De-Scheduling CBD

Articles May 31, 2017

Leaders of the U.S. Senate’s International Narcotics Control Caucus, Sens. Dianne Feinstein (D-CA) and Chuck Grassley (R-IA), introduced a bill entitled the Cannabidiol Research Expansion Act, in the U.S. Senate on May 25, 2017 to expand authorized medical research of cannabidiol (CBD) and to deschedule it from a Schedule I controlled substance. In addition to Feinstein and Grassley, the bill is cosponsored by Senators Dick Durbin (D-Ill.), Thom Tillis (R-N.C.) and Joni Ernst (R-Iowa).

The timing perfectly coincided with the results published in New England Journal of Medicine of a study conducted on Dravet syndrome (suffering from epilepsy) patients concluding that the use of CBD reduced the number of convulsive-seizure frequency.

For more information, contact a member of the Medical Marijuana Practice Group.

Primary Sidebar

Related

Topics

  • Medical Marijuana
© 2023 All Rights Reserved|Tucker Arensberg, P.C.|Log in|Powered by Content Pilot
  • Sitemap
  • Disclaimer
  • Privacy Policy